These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3043033)

  • 1. [Clinical studies on effect of cefbuperazone on surgical infections].
    Kai H; Sugimachi K; Tamada R; Takenaka K; Inuzuka S; Natsuda Y; Taguchi J; Kobayashi M; Kaneko T; Mitarai Y
    Jpn J Antibiot; 1988 Mar; 41(3):322-30. PubMed ID: 3043033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of cefbuperazone in severe infections complicating hematologic diseases Hanshin Infection Study Group].
    Kageyama T; Ohyabu H; Masaoka T; Shibata H; Nagai K; Kitani T; Horiuchi A; Kawagoe H; Yasunaga K; Yonezawa T
    Jpn J Antibiot; 1988 Mar; 41(3):312-21. PubMed ID: 3043032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of transfer of cefbuperazone into postoperative exudates in patients with cancer mastectomy or thyroidectomy].
    Sasaki F; Takada N; Hata Y; Kyunoh K; Uchino J
    Jpn J Antibiot; 1988 Apr; 41(4):460-6. PubMed ID: 3404652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with cefbuperazone in complicated urinary tract infection].
    Banya Y; Okamoto T; Ujiie T; Yoo T; Noro K; Niisato S; Yokota K; Aoki H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1987 May; 33(5):786-93. PubMed ID: 3661345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebrospinal fluid transfer of cefbuperazone in the blood-brain barrier lesions of neurosurgical patients].
    Nakata M; Mukawa J; Miyagi K; Kinjou T; Sakuta O; Miyazato H; Okuyama K; Higa Y; Terada Y
    Jpn J Antibiot; 1990 Jun; 43(6):1174-80. PubMed ID: 2232148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
    Mizuno H; Yamao H; Saito H; Ohno R; Hotta T; Ohnishi K; Murate T; Kagami Y; Mitomo Y; Nitta M
    Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S; Tsuda S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Takino T; Abe T
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the prostatic tissue cefbuperazone (CBPZ) level].
    Fjuii H; Niibori D; Okamura K; Hashimoto H; Tokunaka S; Yachiku S; Osanai H
    Hinyokika Kiyo; 1988 May; 34(5):932-6. PubMed ID: 2459941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of prostatic tissue levels of cefbuperazone].
    Izumi H; Ikeda S; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1987 Aug; 33(8):1316-8. PubMed ID: 2447766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on transfer into lung tissue and postoperative prophylactic effect of new cephamycin antibiotics, particularly cefotetan and cefbuperazone].
    Imaizumi M; Niimi T; Uchida T; Kajita M; Takahashi T; Uchida Y; Asaoka M; Amano Y; Ojika T; Abe T
    Jpn J Antibiot; 1988 Apr; 41(4):437-59. PubMed ID: 3165475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cefminox in the treatment of bacterial infections.
    Omoto S; Watanabe S
    Int J Clin Pharmacol Res; 1990; 10(6):361-8. PubMed ID: 2099361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of cefbuperazone in complicated urinary tract infection].
    Natsume H; Kanai S; Mitsuya E; Miyake K
    Jpn J Antibiot; 1983 Dec; 36(12):3343-8. PubMed ID: 6674546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphological studies of Escherichia coli in the urine of patients with acute simple cystitis treated with cefbuperazone].
    Washida H; Sakagami H; Iwase Y; Sasaki S; Takeuchi K; Inuzuka K
    Hinyokika Kiyo; 1987 Oct; 33(10):1712-7. PubMed ID: 3328503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
    Kumasaka Y; Nakahata H; Hirai Y; Imamura K; Takebe K; Suzuki I; Senda H
    Jpn J Antibiot; 1986 Jan; 39(1):154-8. PubMed ID: 3517405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with cefmetazole in the urological fields].
    Tajima A; Ohmi Y; Masuda H; Ushiyama T; Fujii K; Hata M; Ohta N; Suzuki K; Fujita K; Aso Y
    Jpn J Antibiot; 1982 Aug; 35(8):1961-6. PubMed ID: 6961241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between April 1997 and March 1998].
    Mashita K; Shinagawa N; Sato T; Hirata K; Katsuramaki T; Mukaiya M; Yura J; Ishibiki K; Ushijima Y; Manabe T; Takeyama H; Hasegawa M; Aikawa N; Yamazaki M; Ishikawa S; Iwai S; Kato K; Mizuno A; Kinoshita H; Morimoto K; Konaga E; Takeuchi H; Fujimoto M; Matsuura Y; Takesue Y; Tanimura H; Ohnishi H; Maeda T; Yokoyama T; Hiyama E; Tanaka N; Inoue F; Iwagaki H; Ikeda S; Yasunami Y; Fuchimoto S; Matsumoto Y; Suzuki Y; Tanaka S; Kimura H
    Jpn J Antibiot; 2000 Aug; 53(8):533-65. PubMed ID: 11070817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of severe infection in patients with hematological disorders by cefminox. Tokai Infection Study Group].
    Okumura M; Ohno R; Mitomo Y; Hirano M; Shirakawa S; Yoshikawa S; Kobayashi M; Yamada K
    Jpn J Antibiot; 1985 Jun; 38(6):1619-24. PubMed ID: 3930807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic susceptibility of bacteria isolated from surgical infection (second report)].
    Yura J; Shinagawa N; Ishikawa S; Mizuno A; Hayasaka H; Shiramatsu K; Ishibiki K; Aikawa N; Suzuki H; Takahashi T
    Jpn J Antibiot; 1988 Apr; 41(4):361-89. PubMed ID: 3404649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of cefmetazole for the prevention of postoperative wound infections].
    Konaga E; Mannami T; Fuchimoto S; Haisa M; Orita K; Mano K; Kataoka K; Kimura H; Shimizu J; Fujii H
    Jpn J Antibiot; 1984 Feb; 37(2):247-55. PubMed ID: 6588214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
    Carbon C
    Sem Hop; 1983 Jun; 59(26):1981-4. PubMed ID: 6310791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.